Key result
The editorial discusses the clinical dilemma of balancing the risk of fatal thromboembolism against the risk of fatal bleeding when considering fibrinolysis for acute pulmonary embolism.
Answers are grounded in this paper and cite their sources.
An editorial discussing the clinical dilemma of balancing the risks of fatal thromboembolism and fatal bleeding in the treatment of acute pulmonary embolism.
According to Homer, Odysseus was forced to choose whether to steer his ship closer to Scylla, a six-headed sea monster, or Charybdis, a ship-swallowing whirlpool. Odysseus steered closer to Scylla, risking the loss of a few sailors, rather than risking an entire ship and crew.Much like Odysseus, the physician treating a patient with acute pulmonary embolism occasionally must navigate treacherous waters. The risk of fatal thromboembolism stands on one side, and the risk of fatal bleeding lies just opposite. Unlike Odysseus, the physician has empirical evidence to guide decisions, but tragic outcomes occur sometimes, no matter how carefully the . . .
No takes yet. Share an insight, caveat, or question.
C. Gregory Elliott (2014) conducted an editorial in acute pulmonary embolism. Fibrinolysis was evaluated. The editorial discusses the clinical dilemma of balancing the risk of fatal thromboembolism against the risk of fatal bleeding when considering fibrinolysis for acute pulmonary embolism.
Synapse has enriched 10 related papers. Consider them for comparative context: